Neuromuscular Disorders: Advances in Cellular and Molecular Understanding, Emerging Therapies, and Outcome Measures

A special issue of Cells (ISSN 2073-4409). This special issue belongs to the section "Tissues and Organs".

Deadline for manuscript submissions: 31 December 2025 | Viewed by 91

Special Issue Editors


E-Mail Website
Guest Editor
University Clinical Centre of Serbia-Neurology Clinic, Dr Subotic Street 6, 11000 Belgrade, Serbia
Interests: neuromuscular disorders; CIDP; GBS; MMN; myasthenia gravis; motor neuron diseases; ALS; neuropathic pain

E-Mail Website
Guest Editor
Hannover Medical School, Hannover, Germany
Interests: neuromuscular disorders; motor neuron diseases; SMA; ALS; polyneuropathy

Special Issue Information

Dear Colleagues,

In recent years, our understanding of neuromuscular disorders has undergone a fundamental transformation. These conditions comprise a broad and heterogeneous group of diseases marked by primary damage to structures of the peripheral nervous system, including the anterior horn cells, peripheral nerves, neuromuscular junctions, and muscles. Advances in unraveling their underlying mechanisms have significantly enhanced patient care. Diseases once considered untreatable-such as spinal muscular atrophy-can now be effectively managed with innovative therapies. Moreover, a wide array of treatment options is now available for autoimmune neuromuscular disorders, such as myasthenia gravis or chronic inflammatory demyelinating polyneuropathy. In parallel, the development and refinement of outcome measures continue to support progress in application research and patient management.

This Special Issue aims to collect manuscripts discussing recent advances in neuromuscular research, spanning basic scientific discoveries to applications. We welcome both application and basic research contributions addressing motor neuron disorders (e.g., spinal muscular atrophy, amyotrophic lateral sclerosis), peripheral nerve disorders (including autoimmune conditions such as Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy, as well as hereditary neuropathies), and disorders of muscle and the neuromuscular junction (e.g., muscular dystrophies and myasthenia gravis).

Dr. Ivo Bozovic
Dr. Bogdan Bjelica
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • neuromuscular disorders
  • pathophysiology
  • biomarkers
  • treatment
  • impairment and disability measures
  • outcome measures

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop